IMCR

Immunocore (IMCR)

Immunocore Holdings PLC

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:IMCR

1 2 3 4 5 6 7 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/06/01	21:00	GlobeNewswire Inc.	Immunocore presents KIMMTRAK clinical data demonstrating that patients with stable disease and confirmed tumor reduction have similar clinical outcomes to patients with partial response	NASDAQ:IMCR	Immunocore Holdings PLC
2024/06/01	05:21	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:IMCR	Immunocore Holdings PLC
2024/06/01	05:05	GlobeNewswire Inc.	Immunocore reports updated Phase 1 data of brenetafusp (IMC-F106C), an ImmTAC bispecific targeting PRAME, in immune checkpoint pre-treated cutaneous melanoma patients at ASCO 2024	NASDAQ:IMCR	Immunocore Holdings PLC
2024/05/31	05:00	GlobeNewswire Inc.	Immunocore to present at the Jefferies Global Healthcare Conference	NASDAQ:IMCR	Immunocore Holdings PLC
2024/05/29	20:00	GlobeNewswire Inc.	Immunocore converts Phase 2/3 TEBE-AM clinical trial into registrational Phase 3 trial evaluating KIMMTRAK for previously treated advanced cutaneous melanoma	NASDAQ:IMCR	Immunocore Holdings PLC
2024/05/29	05:17	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:IMCR	Immunocore Holdings PLC
2024/05/29	05:15	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:IMCR	Immunocore Holdings PLC
2024/05/29	05:15	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:IMCR	Immunocore Holdings PLC
2024/05/29	05:15	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:IMCR	Immunocore Holdings PLC
2024/05/29	05:15	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:IMCR	Immunocore Holdings PLC
2024/05/24	05:50	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:IMCR	Immunocore Holdings PLC
2024/05/08	20:13	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:IMCR	Immunocore Holdings PLC
2024/05/08	20:00	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:IMCR	Immunocore Holdings PLC
2024/05/08	20:00	GlobeNewswire Inc.	Immunocore reports first quarter financial results and provides a business update	NASDAQ:IMCR	Immunocore Holdings PLC
2024/04/24	23:00	GlobeNewswire Inc.	Immunocore announces upcoming presentation and posters at ASCO 2024	NASDAQ:IMCR	Immunocore Holdings PLC
2024/04/05	05:00	GlobeNewswire Inc.	Immunocore to present at upcoming investor conferences	NASDAQ:IMCR	Immunocore Holdings PLC
2024/03/06	06:30	GlobeNewswire Inc.	Immunocore presented two posters at CROI 2024	NASDAQ:IMCR	Immunocore Holdings PLC
2024/03/01	21:00	GlobeNewswire Inc.	Immunocore to present at upcoming investor conferences	NASDAQ:IMCR	Immunocore Holdings PLC
2024/02/29	06:19	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:IMCR	Immunocore Holdings PLC
2024/02/29	06:15	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:IMCR	Immunocore Holdings PLC
2024/02/28	21:34	GlobeNewswire Inc.	Immunocore reports fourth quarter and full year 2023 financial results and provides a business update	NASDAQ:IMCR	Immunocore Holdings PLC
2024/02/28	21:33	Edgar (US Regulatory)	Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]	NASDAQ:IMCR	Immunocore Holdings PLC
2024/02/27	08:46	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:IMCR	Immunocore Holdings PLC
2024/02/22	21:00	GlobeNewswire Inc.	Immunocore announces clinical trial collaboration and supply agreement with Bristol Myers Squibb to evaluate IMC-F106C (PRAME HLA-A02) in combination with nivolumab in its registrational Phase 3 first-line advanced cutaneous melanoma trial	NASDAQ:IMCR	Immunocore Holdings PLC
2024/02/22	06:16	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:IMCR	Immunocore Holdings PLC
2024/02/22	06:15	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:IMCR	Immunocore Holdings PLC
2024/02/22	06:15	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:IMCR	Immunocore Holdings PLC
2024/02/22	06:15	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:IMCR	Immunocore Holdings PLC
2024/02/22	06:15	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:IMCR	Immunocore Holdings PLC
2024/02/21	21:00	GlobeNewswire Inc.	Immunocore to report fourth quarter and full year 2023 financial results and host call on February 28, 2024	NASDAQ:IMCR	Immunocore Holdings PLC